Ponatinib and its role in treating ALL
New subtypes of acute lymphoblastic leukemia (ALL) – potential treatment identification by genomics
Developments in CML over the past 30 years and where we are today
What impact do side effects have on elderly chronic myeloid leukemia (CML) patients?
Treatment-free remission (TFR) – the safety of stopping treatment in chronic myeloid leukemia (CML)